Atrial Fibrillation Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are at least 18 years old at the time of signing the consent form
• People who are already scheduled to have a catheter ablation procedure to treat atrial flutter (AFL) or atrial fibrillation (AF), as recommended by their doctor following standard medical guidelines
• People who are able to understand what the study involves and are willing to sign a written consent form
• People who are able and willing to attend all required study visits at an approved trial location

Who may not be able to join:

• People for whom the trial's special imaging catheter (called VERAFEYE) cannot be safely or practically used, as determined by their doctor
• People who are pregnant or planning to become pregnant during the study period (a negative pregnancy test taken within the 7 days before the procedure is required for women who may be able to become pregnant)
• People who have an implanted heart device such as a pacemaker, cardiac resynchronisation therapy (CRT) device, or implantable cardioverter-defibrillator (ICD)
• People who still have unresolved complications or side effects from a previous invasive medical procedure
• People who have another surgical or blood vessel procedure planned within 30 days before or after the ablation procedure
• People whose life expectancy is estimated to be less than 12 months
• People who have a blood clot in the left upper chamber of the heart (left atrial thrombus) — screening for this must be done within 48 hours before or during the procedure, and the procedure will not go ahead if a clot is found (confirm with trial site regarding rescheduling conditions)
• People who are currently taking part in another clinical study

Important: Always verify eligibility with the trial site directly before applying.